Detection of Prostate Cancer using Tumor markers and Biopsy in outpatients
in Kerbala city, Iraq
Hassan Ali Al-Saadi1 and Mohammed Salih Mahdi**
1Department of Clinical Laboratory Sciences/College of Pharmacy/University of Kerbala, IRAQ
2Department of Immunology /Al-Hussein Teaching Hospital/Kerbala Health Directorate, Kerbala, IRAQ
Available online at: www.isca.in
Received 23rd July 2013, revised 8th August 2013, accepted 21st August 2013
Prostate cancer incidence and mortality rates vary worldwide. This led to the investigation the prostate specific antigen for detection prostate cancer in the serum of patients by using tumor markers and histopatological procedures. Prostate specific antigen levels of 4–10 ng/mL participated in a protocol for prostate cancer using Analytical immune assay AIA 360, and used histopathological procedure for prostate cancer diagnosis. One hundred and fifty Clinical symptoms (75 PSA,75 control) of prostate cancer were included mean and SD of PSA at ages (20-40,41-50,51-60,61-70,71-80,81-90) higher than mean and SD of control especially age group (71-80) was (9.18±3.56) high significant more than another age groups at (p 0.05) compare with control twenty two, twelve and ten patients were suffering from prostate expansion at age groups (71-80), (81- 90), (61-70) respectively, testis surgery and CA prostate were (6,5) respectively at the same age groups, prostate inflammation was (7) at age group (71-80) more than another age groups. Adenocarcinoma, hyperplasia, benign, hemorrhagic, testicular mass, and hypoplasia were 20(26.66%), 25 (33.33%), 12(16%), 8(10.66%), 1(1.33%), 9(12%). The PSA using has led to overdiagnosis and resulting to dissolve controversy and histopathological tools to enhanced prostate diagnosis and help in early detection about prostate cancer at males that appointed physicians to set suitable drugs for patients, so early diagnosis by these techniques prevent the complications appearance at patients which led to mortality.